Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: New energy, heath, and transport opportunities

Canada’s largest financial portal for Canadian small-cap investors is right here at Stockhouse. It is where our Bullboards – your Bullboards – are a leading forum to discuss these Canadian-listed small-cap businesses. Stocks on both sides of the border...
Jonathon Brown | October 19, 2023 |

Unlocking the Healing Potential of Safe, Natural Psychedelics

When we last caught up with Filament Health Corp. ( NEO.FH , Forum ) and their CEO and Co-Founder, Ben Lightburn last July , our Stockhouse investors were introduced to an industry leader in exclusively-natural psychedelic drug discovery and extraction. The company enga...
Dave Jackson | April 11, 2022 |

Price-Leading Fuel Cell Technology with Zero CO2 Emissions

A fuel cell is a clean electrical power conversion/generation system, akin to a small power station that provides electricity and an equivalent amount of heat for various purposes. Alkaline Fuel Cell Power Corp. ( NEO.PWWR , Forum ) is at the forefront of this technolo...
Dave Jackson | September 24, 2021 |

New Year, New Opportunity, New Rich Targets Discovered by Canadian Jr. Miner

(Map via Avrupa Minerals Ltd.) There is a lot of excitement around the offices of Avrupa Minerals Ltd. ( TSX-V: AVU , OTC: AVPMF , Forum ) and at its Alvalade Project in Alentejo, Portugal, where it holds a 100%-owned experimental exploitation license. ...
Jonathon Brown | March 5, 2021 |

Minimizing Mining Risk: The “Hybrid Opportunity Generator”

What sets certain companies apart from most others in the early-stage exploration space? A lot of the time it’s simply thinking outside of the box. In the case of Vancouver, BC-based junior exploration and development company Avrupa Minerals Ltd. (AVU)...
Dave Jackson | December 4, 2020 |

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac ( NASDAQ: CVAC ) recently started its phase study IIa in Peru and Panama. Around 700 people...
Nico Popp | October 16, 2020 |

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity

These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. In a June 22 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Targovax ASA's (TRVX:OSE) ONCOS-102, in trial ...
Streetwise Reports | June 25, 2020 |

Covid, debt and precious metals

Precious metals are loving the uncertainty the coronavirus has created. Despite limited successes some countries have had with reopening, the virus is nowhere near contained. As of this writing, close to 6 million worldwide are infected and 365,328 have died. The importan...
Richard (Rick) Mills | June 1, 2020 |

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS

Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its all...
Streetwise Reports | April 27, 2020 |
1 2
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested